title: Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea.
abstract: This study evaluated the effect of supplementation with canine-derived probiotic Bifidobacterium animalis strain AHC7 (lams Prostora, Procter & Gamble Pet Care) on the resolution rate of acute idiopathic diarrhea in dogs randomly assigned to receive a placebo (n=18) or the probiotic (n=13). Nutritional management with the probiotic fed at 2 x 10(10) CFU/day significantly reduced the time to resolution (3.9 +/- 2.3 versus 6.6 +/- 2.7 days; P < .01) and reduced the percentage of dogs that were administered metronidazole (38.5% versus 50.0%) compared with placebo. Probiotic B. animalis AHC7 may provide veterinarians another tool for management of acute diarrhea in dogs.
authors.affiliation: Procter & Gamble Pet Care Technical Center 6571 State Route 503 North Lewisburg, OH 45338, USA. kelley.rl@pg.com
authors.forename: R L
authors.initials: RL
authors.lastname: Kelley
authors.forename: Debbie
authors.initials: D
authors.lastname: Minikhiem
authors.forename: Barry
authors.initials: B
authors.lastname: Kiely
authors.forename: Liam
authors.initials: L
authors.lastname: O'Mahony
authors.forename: David
authors.initials: D
authors.lastname: O'Sullivan
authors.forename: Tom
authors.initials: T
authors.lastname: Boileau
authors.forename: Jean Soon
authors.initials: JS
authors.lastname: Park
mesh_terms: D000821:Animal Feed / Q000032:analysis*; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001644:Bifidobacterium; D003967:Diarrhea / Q000628:therapy / Q000662:veterinary*; D004032:Diet / Q000662:veterinary*; D004283:Dog Diseases / Q000628:therapy*; D004285:Dogs; D008795:Metronidazole / Q000627:therapeutic use; D019936:Probiotics
chemical_list: D000890:Anti-Infective Agents; D008795:Metronidazole